Tag: WHO

  • More than 116m people living with mental health conditions in Africa

    More than 116m people living with mental health conditions in Africa

    The World Health Organisation (WHO) has said  that more than 116 million people are estimated to be living with mental health conditions in Africa.

    Dr Matshidiso Moeti WHO Regional Director for Africa said this in Abuja in a message to mark the 2022 World Mental Health Day which has the theme, “Make Mental Health and Wellbeing for All a Global Priority”.

    According to her, the day provides an opportunity to draw attention to Africa’s large and growing burden of mental health conditions, with children and adolescents most impacted.

    “The theme serves as a reminder that after nearly three years, the social isolation, fear of disease and death, and strained socio-economic circumstances associated with the COVID-19 pandemic have contributed to an estimated 25 per cent global rise in depression and anxiety.

    “Across the African Region, more than 116 million people were already estimated to be living with mental health conditions pre-pandemic,’’ she said.

    Moeti said the rate of suicide remained particularly a thing of concern given the exponential rates of alcohol use and abuse among adolescents as young as 13 years of age.

    She said Africa needed to urgently strengthen regulatory systems to close the gaps that allowed young people to easily access alcohol.

    “Sure act contributes to heavy episodic drinking rates as high as 80 per cent among teens from 15 to 19,’’ Moeti said.

    She added that the situation posed a serious threat to their education, while setting the stage for a lifetime of alcohol abuse, and the associated risks of noncommunicable and other related diseases.

    According to her, inadequate financing for mental health continues to be the biggest limitation, negatively impacting efforts to expand Africa’s mental health workforce.

    The WHO director maintained that there are fewer than two mental health workers for every 100 000 people, the majority of whom are psychiatric nurses and mental health nursing aids.

    She said that with scarce resources concentrated at large psychiatric institutions in urban areas, people at the community and primary care levels are left critically underserved.

    “For example, while two-thirds of member states report having guidelines to integrate mental health into primary health care, fewer than 11 per cent are providing pharmacological or psychological interventions at this level.

    “It is, however, heartening that up to 82 per cent of our member states are receiving training on how to manage mental health conditions at primary care level.

    “With up to 74 per cent reporting that specialists are involved in providing appropriate training and supervision to primary health care professionals,’’ she said.

    Moeti stated that African governments have made some progress on mental health spending.

    She, however , said the spending pattern was still well below the recommended two dollars per person, with mental health not featuring in national health insurance schemes.

    To address the challenge, she advised, member states should follow ensure the implementation of commitments they made at the Regional Committee in August 2022.

    She said the commitment was done when they endorsed the Framework to Implement the Comprehensive Global Action Plan 2013 to 2023 in the WHO African Region.

    The director said that the key document highlighted the severe shortage of mental health services on the continent, and makes recommendations for key actions by member states.

    Moeti said countries needed to strengthen the mental health and psychosocial response in humanitarian emergencies, including COVID-19 and Ebola, which have a significant negative impact on school-age children and our health care workers.

    She said that mental health and psychosocial support are integral to any successful response.

    “On this day let us all commit to work together to deepen the value we afford to mental health.

    “To reshape the environments that negatively impact mental health, and to strengthen the care systems to make mental health care accessible to all Africans.’’ Moeti said.

  • Nigeria on alert mode as Ebola resurfaces in Uganda

    Nigeria on alert mode as Ebola resurfaces in Uganda

    The Nigeria Centre for Disease Control and Prevention (NCDC) says it is aware of the ongoing outbreak of Ebola Virus Disease (EVD) caused by the Sudan strain of the Ebola Virus (EV) in Uganda.

    The Director-General, NCDC, Dr Ifedayo Adetifa, in a statement on Tuesday in Abuja, said that Uganda had, on Sept. 20, declared the outbreak of the virus and that it was on an alert mode.

    The outbreak has also been confirmed by the World Health Organization (WHO).

    The Sudan strain of the Ebola virus is the known cause of EVD, having caused previous outbreaks in Uganda, South Sudan, and the Democratic Republic of Congo.

    The Uganda Virus Research Institute confirmed the virus in samples collected from a 24-year old male, who had exhibited symptoms of the disease and later died in Mubende District in the Central Region, about 175km from the capital, Kampala.

    As of Sept. 29, the Ugandan Ministry of Health reported 54 cases (35 confirmed and 19 probable) and 25 deaths (7 confirmed and 18 probable).

    The Ugandan Ministry of Health, with the support of WHO, is working to effectively respond to and contain the spread of the virus.

    The NCDC boss said that the agency’s -led multisectoral National Emerging Viral Haemorrhagic Diseases Technical Working Group (NEVHD TWG), working with partners and stakeholders, had conducted a rapid risk assessment to guide in-country preparedness activities.

    “The NEVHD TWG coordinates preparedness efforts for EVD and other emerging viral haemorrhagic diseases.

    “Based on available data, the overall risk of importation of the Ebola virus and the impact on the health of Nigerians has been assessed as high for the following reasons:

    “The Sudan Ebola Virus does not currently have an effective drug for treatment or licensed vaccine for prevention.

    “The extent of the outbreak in Uganda has not yet been ascertained as investigations have shown that some persons may have died with similar symptoms which were not reported to health authorities.

    “In addition, their burials were not conducted safely to prevent transmission.

    “The case fatality rate of the Sudan virus varied from 41 per cent to 100 per cent in past outbreaks.

    “The likelihood of importation to Nigeria is high, due to the increased air travel between Nigeria and Uganda, especially through Kenya’s Nairobi airport, a regional transport hub, and other neighbouring countries that shared a direct border with Uganda.

    “The likelihood of spread in Nigeria following importation is high due to the gatherings and travel associated with politics, the coming yuletide as well as other religious gatherings and festivals during the last few months of the year,” he outlined.

    He said that in spite of the risk assessment, the country had the capacity – technical, human (health workforce), and diagnostic – to respond effectively in the event of an outbreak.

    “This is exemplified by our successful response to the Ebola outbreak in 2014, as well as improvements in our capacity for health emergency response during the COVID-19 pandemic.

    “We have the diagnostic capacity to test for the EVD presently at the National Reference Laboratory in Abuja and the Lagos University Teaching Hospital’s Centre for Human and Zoonotic Virology Laboratory,” he said.

    He, however, said that diagnostic capacity would be scaled up to other laboratories in cities with important Points of Entry (POE) and others as might be required.

    “An effective response system is in place with the availability of control capacities (trained rapid response teams, and an effective infection prevention and control programme) to limit the risk of spread in the event of a single imported case.

    “Currently, no case of EVD has been reported in Nigeria. Nonetheless, the Nigerian Government, through NCDC’s multisectoral NEVHD TWG, has put several measures in place to prevent and prepare for immediate control of any outbreak of the disease in-country.

    “The NCDC Incident Coordination Centre (ICC) is now in alert mode. Development of an incident action plan for the first few cases of EVD has commenced.

    “POE surveillance has been heightened, using the passenger pre-boarding health declaration and screening form in the Nigeria International Travel Portal (NITP) platform.

    “Passengers arriving from Uganda and persons who transited in Uganda are being followed up for 21 days of their arrival in Nigeria on their health status.

    “Trained Rapid Response Teams are on standby to be deployed in the event of an outbreak.

    Public Health Emergency Operations Centres (PHEOCs) in states with major POE i.e. Lagos, Kano, Abuja, and Rivers are on standby.

    “A medical counter measures plan is available.”

    He said amplification of risk communication and engagement with states and partners, to strengthen preparedness activities including a review of risk communication protocols, plans and messages in the event of an outbreak, had been done.

    Adetifa said the country had an active infection Prevention and Control (IPC) programme nationwide with guidelines and training packages developed for healthcare workers.

    Ebola virus disease is a severe, often fatal illness affecting humans. The strain responsible for the current outbreak was first reported in southern Sudan in June 1976.

    Since then, seven outbreaks caused by this strain had been reported (four in Uganda and three in Sudan) with previous outbreaks’ fatality ratio ranging from 41 to 100 per cent.

    Just like other types of Ebola virus, people infected cannot spread the disease until the development of symptoms, including fever, fatigue, muscle pain, headache, and sore throat later followed by vomiting, diarrhoea, rash, symptoms of impaired kidney and liver function.

    Symptoms may appear anywhere from two to 21 days after exposure to the virus, but the average is 8 to 10 days.

    Currently, there are no vaccines or therapeutics for the prevention and treatment of this strain of the virus.

    However, the early initiation of supportive treatment has been shown to significantly reduce deaths.

    Recovery from EVD depends on good supportive clinical care, management of co-morbidities, and the patient’s immune response.

    People who recover from Ebola virus infection develop antibodies that last for at least 10 years.

  • How medication errors kill 3 million annually – WHO

    How medication errors kill 3 million annually – WHO

    Medication errors contribute to more than three million deaths globally every year, World Health Organization’s (WHO) Regional Director for Africa, Dr Matshidiso Moeti has disclosed.

    TheNewsGuru.com (TNG) reports Dr Moeti disclosed this in her message to mark the 2022 World Patient Safety Day.

    World Patient Safety Day is observed annually on Sept. 17 to raise global awareness about patient safety and to call for solidarity and united action by all countries and international partners to reduce patient harm.

    Moeti said the Days aims at raising awareness of the importance of people-centred care and preventing harm to patients.

    She noted that medication errors were exacerbated by overwhelmed health systems during the COVID-19 pandemic. According to her, about one in every four cases of preventable medication harm is clinically severe, or life-threatening.

    “While there is limited data for the African continent, it is generally acknowledged that there is a high magnitude of unsafe medication practices,” she noted.

    Moeti said that the Day was specifically designed to draw attention to the need to improve systems to support safe medication and address unsafe practices.

    According to her, it focuses on three primary areas – high-risk situations, transitions of care and “polypharmacy’’, which is the use of multiple medicines at once.

    “Poly pharmacies are particularly common amongst older people with chronic health diseases. Medication errors occur because of weaknesses in medication systems and are aggravated by shortages of well-trained health staff and poor working and environmental conditions for delivery of quality healthcare.

    “Among low and medium-income countries, the African region has the highest prevalence of substandard and counterfeit medicines of about 18.7 per cent,’’ she said.

    She decried the administration of surplus medication at home; the purchase of medication from pharmacies on the advice of friends and relatives rather than on prescription by trained professionals.

    Moeti stressed that the use of old prescriptions to buy medication to treat a current ailment is a common practice that should be stopped.

    “One study done in 2021 showed that as many as one in every three respondents admitted to self-medication to prevent COVID-19.

    “This is unacceptably high because such unguided practices lead to dangerous consequences as a result of drug interactions.

    “It also leads to incorrect administration, dosage or choice of treatment. Consequences include delays in treating diseases, dependence and abuse, disability, and even death,’’ she lamented.

    Moeti noted that medication systems and human factors were major contributory factors to unsafe practices.

    She noted also that many countries lacked the capacity to detect, evaluate and prevent medicine safety issues.

    She said illiteracy, language difficulties, as well as socio-cultural and religious beliefs, also played roles in exacerbating medication errors.

    “Based on current estimates, 42 billion dollars of total health expenditure worldwide could be averted if medication errors are addressed.

    “Medication without harm aims to reduce severe avoidable medication-related harm by 50 per cent globally in the next five years,

    “This will be done through focused activities and interventions targeting three areas – patients and the public; health care professionals and medicines and systems and medication practices,’’ she added.

    Moeti said that WHO was working with member states to implement the Global Patient Safety Action Plan 2021 – 2030.

    “A regional patient safety strategy and road map are currently being developed to guide its implementation.

    “Some notable highlights include support to establish and strengthen National Medicine Regulatory Authorities (NRAs), by building regulatory capacity and promoting regulatory harmonisation.

    “Strengthened regulatory systems serve to eliminate barriers which impede access to safe, effective and quality-assured medical products.

    “WHO already developed tools to assist member states in benchmarking NRAs to identify strengths and implement plans to address weaknesses.

    “Ghana, Nigeria and Tanzania have already attained Maturity Level 3, indicating their regulatory systems are functioning well, and integrating the requisite elements to guarantee stable performance.

    “This reduces their vulnerability to substandard and falsified medical products,’’ she stressed.

    Moeti said that 39 WHO member states had developed essential medicines lists linked to standard treatment guidelines.

    According to her, 25 member states have also developed national medicine formularies that guide the selection of medicines for procurement, prescription and dispensing practices.

    Moeti encouraged healthcare to take a more active role in ensuring safer medication practices, and medication-use processes.

  • WHO releases 6 policy briefs to end COVID-19

    WHO releases 6 policy briefs to end COVID-19

    World Health Organisation (WHO) on Wednesday released six short policy briefs that outline key actions that all governments must take to end the COVID-19 pandemic.

    WHO Director General, Tedros Ghebreyesus, announced this at a news conference at the UN health agency’s headquarters in Geneva.

    He said the policy briefs are based on evidence and experiences of the last 32 months, outlining what works best to save lives, protect health systems, and avoid social and economic disruption.

    He added that the briefs will serve as urgent call for governments to take a hard look at their policies and strengthen them for COVID-19 and future pathogens with pandemic potential.

    He explained that the documents, which are available online, include recommendations regarding vaccination of most at-risk groups, continued testing and sequencing of the SARS-CoV-2 virus, and integrating effective treatment for COVID-19 into primary healthcare systems.

    He, therefore, urged authorities to have plans for future surges, including securing supplies, equipment, and extra health workers.

    The briefs also contain communications advice, including training health workers to identify and address misinformation, as well as creating high-quality informative materials, he added.

    He said WHO had been working since New Year’s Eve 2019 to fight against the spread of COVID-19 “and will continue to do so until the pandemic is truly over.

    “We can end this pandemic together, but only if all countries, manufacturers, communities and individuals step up and seize this opportunity.”

    According to him, as the number of weekly reported deaths from COVID-19 plunged to its lowest since March 2020, the end of the pandemic is now in sight.

    He said “we have never been in a better position to end the pandemic. However, the world is not there yet. A marathon runner does not stop when the finish line comes into view. She runs harder, with all the energy she has left. So must we.

    “We can see the finish line. We’re in a winning position. But now is the worst time to stop running. The policy briefs outline the key actions that all governments must take now to finish the race”.

  • More than 700,000 people commit suicide annually – W.H.O

    More than 700,000 people commit suicide annually – W.H.O

    The World Health Organisation (WHO) says more than 700,000 people commit suicide globally every year with 77 per cent of all global suicides occurring in low and middle income countries.

    WHO Country Representative to Nigeria, Dr Walter Mulombo, said this in a message to commemorate the 2022 World Suicide Prevention Day (WSPD).

    Mulombo said that the day which was being celebrated on Sept. 10 yearly was aimed at raising the much needed awareness that suicide was preventable.

    “For every suicide, there are likely 20 other people making a suicide attempt and many more have serious thoughts of suicide.

    ”Suicide is the fourth leading cause of deaths among 15 to 29-year-old people,’’ he said.

    The 2022 theme is: “Creating hope through action” which serves as a reminder that there is alternative to suicide.

    He said ”the theme also aspires to inspire confidence and light in all of us, aimed to empower individuals to be in charge of their lives and value the one life they have.”

    Mulombo said that creating hope through action highlights the importance of setting suicide prevention as a priority public health agenda by countries.

    He said that this is particularly so where access to mental health services and availability of evidence based interventions were already low.

    “Every suicide is a tragedy that has an impact on the people left behind, families, communities, and the entire nation.

    “I will begin by commending the Minister of Health, Dr Osagie Ehanire and his team for their commitment to suicide prevention in Nigeria.

    “Suicides are preventable with timely, evidence based and often low cost interventions.

    ”For national responses to be effective, a comprehensive multisectoral suicide prevention strategy is needed,” Mulombo said.

    He said in 2013, the World Health Assembly adopted the Mental Health Action Plan 2013 to 2020.

    Also Read

    Nigerias World Bank debt rises to $21.15b from $12.72b

    Mulombo said the plan identified suicide prevention as an important priority for achieving the global target of reducing the rate of suicide in countries by 10 per cent by 2020.

    He said that Nigeria has shown commitment to the target by first establishing the new National Mental Health Programme in ministry of health.

    According to him, the ministry provided strategic leadership on mental health activities and also worked closely with the National Assembly to develop a new mental health bill which aligned with international standards.

    “We are all eagerly awaiting the assent of this bill by President Muhammadu Buhari.

    “As WHO, we pledge to continue supporting the country to implement priority activities towards mental health including suicide prevention and control.

    “In the coming weeks, we will be supporting the review and update of the 2013 National Mental Health Policy, the development of a national framework for suicide prevention and the commemoration of the day.

    “In conclusion, together, by raising awareness, reducing the stigma around suicide, and encouraging well-informed action, we can reduce instances of suicide in our country and inadvertently around the world,’’ he said.

    Mulombo said the organisation would play a role in supporting people experiencing a suicidal crisis or those bereaved by suicide whether as a member of society.

    “We can all create hope through action and be the light,’’ he said.

    According to him, suicide remains a serious public health concern with a profound impact on all.

  • Yellow Fever: NCDC reports 14 deaths in 10 states

    Yellow Fever: NCDC reports 14 deaths in 10 states

    The Nigeria Centre for Disease Control and Prevention (NCDC) has recorded 14 deaths in 10 states from suspected cases of yellow fever from January to July 2022.

    The NCDC made this known via its official website on Sunday.

    It listed the affected states as Abia -one, Bayelsa -one, Benue- one, Imo- one, Kaduna- one, Katsina – two, Kebbi -two, Taraba -two, Yobe -one and Zamfara -three.

    Newsmen reports that the World Health Organisation (WHO) described yellow fever as an acute viral haemorrhagic disease transmitted by infected mosquitoes.

    The “yellow” in the name refers to jaundice that affects some patients.

    The symptoms of yellow fever include headache, jaundice, muscle pain, nausea, vomiting and fatigue.

    A small proportion of patients who contract the virus, however, develop severe symptoms, and approximately half of those die within seven to 10 days.

    The Nigerian Public Health Institute said that cumulatively a total of 1,179 suspected cases of yellow fever were reported from 416 local government areas between January 1 and July 31.

    It said that one case each was confirmed from Sokoto, Osun, Ondo, Anambra and Imo states.

    The NCDC said that male to female ratio for suspected cases was 1:1.7 with males recording 637 cases (54 per cent) and females, 542 cases (46 per cent).

    It stated that 74 per cent of cases were aged 30 years and below.

    “One hundred and twenty-six (10.7 per cent) of 1,179 suspected cases has had at least one dose of the yellow fever vaccine,” it said.

    The centre said that it was coordinating response activities through the National Multi-Agency Yellow Fever Technical Working Group.

    Newsmen reports that the impact of the COVID-19 pandemic continues to be felt across several other areas including the increase in the risk of measles and yellow fever outbreaks due to delayed planned vaccination campaigns.

    Meanwhile, yellow fever is preventable with an extremely effective vaccine that is safe and affordable.

    A single dose of yellow fever vaccine is sufficient to grant sustained immunity and life-long protection against yellow fever disease.

    A booster dose of the vaccine is not needed.

    The NCDC revealed efforts to support Nigeria in preventive mass vaccination campaigns (PMVCs), through its Eliminate Yellow fever Epidemics (EYE) Strategy.

    It said it would be reaching out to states like Ogun, Gombe, Kano, Adamawa, Bayelsa, Borno and Enugu before the end of 2022.

    “Further yellow fever vaccination campaigns are planned in Nigeria in the states of Ogun and Gombe States in June 2022,” it said.

    It added that these campaigns targeted 8.8 million people for protection, while additional PMVCs will be implemented in the latter part of 2022 in Kano, Adamawa, Bayelsa, Borno and Enugu state.

  • Pry healthcare: Experts blame increasing child mortality on corruption

    Pry healthcare: Experts blame increasing child mortality on corruption

     

    Worried by rising maternal and child mortality in communities across Nigeria, a medical doctor, and public health expert, Dr. Laz Ude, has lamented that the activities of corrupt health workers continue to undermine the ability of Primary Health Centers (PHCs) to deliver sound service.

    This assertion is coming against the backdrop of an investigative report exposing that maternal and child mortality is still increasing in Nasarawa State despite humongous sums spent on ‘The Saving One Million Lives Program for Results (SOML PforR).

    The Federal Government had initiated SOML PforR to stem the tide of maternal and child mortality in the country and save an estimated 900,000 women and children that die each year from preventable causes.

    Speaking during an anti-corruption radio programme, PUBLIC CONSCIENCE, produced by the Progressive Impact Organization for Community Development, PRIMORG, in Abuja, Dr. Ude stressed that besides corruption, PHCs are weakened by inadequate numbers of health workers.

    According to him, there is no value for the $500m Nigeria received for the Save One Million Lives project, arguing that the Program may not have been able to save up to a thousand pregnant women. He added that health workers in PHCs compound the problem by indulging in stealing drugs, diverting drugs to their private clinics, or selling the stolen drugs somewhere.

    “I’m not sure if we’ve saved a thousand lives because the NDHS survey showed an increase in maternal mortality between 2013 and 2018 National Demographic and Health Survey, which is not good at all. We are not getting value for money.

    “A lot of things are being covered by corruption, but specifically, sometimes medications are made available, sometimes the health workers may sell a part of them or channel some to their private clinics – the bad ones among them, not all of them do that; people go to health centers and steal drugs or supplies to go and sell,” Ude stated.

    To curb the corruption bedeviling service delivery in PHCs, the health expert called for the strengthening of Village Health Committees and citizens to get involved and help the government tackle corruption in PHCs as they cannot do it alone.

    “The National Health Act 2014 and the World Health Systems 2018 made available for every village and community to have a health committee, and that’s like the ministry of health within that community or town.

    “This committee draws the attention to the primary health needs of the community and also helps to solve needs they can afford and make sure that their elected representatives hold health care workers accountable.”

    On her part, a media consultant and activist, Princess Halima Jubril, backed the strengthening of communities to monitor the day-to-day running of PHCs, which will, in turn, help the government reduce corruption in PHCs.

    Princess Jubril urged people living in rural areas affected by the prevalence of corruption to help the government and themselves check stealing at PHCs.

    “They should know it is just a volunteer job for your wives, your daughters, and your children not to die so that you will keep your children in the primary health care center, monitor the activities of the primary health center, and make sure that what is supposed to be done there is done right,” She advised.

    She noted that corruption was majorly responsible for the state of PHCs in Nigeria, stating that Nigeria does not have value for investments made in the health sector over the years.

    “When you look at the amount that international agencies have put into the Nigeria health sector, apart from that fact that Nigeria’s federal allocation to health is the lowest in Africa but then there has been so much assistance from the world bank, but so many of the funds are largely unaccounted for, “Princess Jubril averred.

    Earlier, investigative journalist Elijah Akoji said that despite the $1 million Nasarawa State received through the Saving One Million Lives Program in 2016, another $7.5 million PHCs are nothing to write about in local government areas of the state.

    His words: “The deplorable state of primary health care centers in Nasarawa is something to be worried about. For example, in Boku community, primary health care is like a place where you cannot rear birds.

    “We discovered that some of these women patronize traditional system, some of them prefer to go and deliver there instead of going to the hospitals, because there are no experienced midwives that will cater for them, no good facility, few workers and all this begin to raise the question that happened to the fund that is supposed to provide all that is missing,” Akoji disclosed.

    Nasarawa state records over 100 deaths of women annually through childbirth, especially across rural communities. According to the World Health Organisation (WHO), Nigeria accounts for over 34 percent of global maternal deaths.

    Public Conscience is a syndicated weekly anti-corruption radio program used by PRIMORG to draw government and citizens’ attention to corruption and integrity issues in Nigeria.

    The program has the support of the MacArthur Foundation.

  • Why Buhari appointed Aliko Dangote to head 16-member council

    Why Buhari appointed Aliko Dangote to head 16-member council

    Details have emerged on why President Muhammadu Buhari appointed the founder and president of Dangote Group, Alhaji Aliko Dangote to head the 16-member Nigeria End Malaria Council (NEMC).

    TheNewsGuru.com (TNG) reports President Buhari on Tuesday in Abuja inaugurated NEMC, projecting that the successful implementation of the Council’s agenda and savings from the estimated economic burden of the disease would save Nigeria about N687 billion in 2022 and N2 trillion by 2030.

    Buhari told the 16-member Council that beyond improving the quality of life, health and well-being of Nigerians, the concerted strategy to tackle malaria had both public health as well as socio-economic benefits for Nigeria.

    “Our inauguration today will therefore ensure that malaria elimination remains a priority on our agenda, with strong political commitment from leaders at all levels. Additionally, the End Malaria Council will provide a platform to advocate for more funding to protect and sustain progress made so far by our country, and put us on a pathway to ending malaria for good,” Buhari said.

    Expressing concern that the age-long disease had remained a major public health challenge in Nigeria, the President cited the World Health Organisation (WHO) report of 2021, showing that Nigeria alone accounts for 27 per cent of all cases of malaria and 32 per cent of deaths globally.

    “Malaria infection can cause severe disease and complication in pregnant women and lead to high rates of miscarriage. It is also responsible for a considerable proportion of deaths in infants and young children, with children under 5 years being the most vulnerable group affected. These are reasons we must not relent in fighting malaria,” he said.

    On his choice of Dangote to chair the Council, President Buhari explained that it was in recognition of the track record and passion of Africa’s richest man in supporting initiatives on various health issues such as polio and primary health care system strengthening.

    He expressed confidence that Dangote would bring his outstanding achievements to help the country achieve its goal of malaria elimination, adding that a group of eminent personalities, who have also made their mark across all walks of life, have been selected to work in the Council.

    He added that the membership of the Council reflects Government’s commitment to significantly reducing the malaria burden in Nigeria, to a level where it is no longer a public health issue.

    “I have been informed that the End Malaria Council (EMC) has already been established in other African countries, in line with the African Union Assembly Declaration for Establishment of EMC’s in Africa. EMCs have provided leadership, new funding and innovation to enable these countries stay on track to meet malaria burden reduction targets, and I am optimistic that the setting up of the Nigeria End Malaria Council will do the same for Nigeria.

    “I must add that with the additional advocacy and funding the Council will bring to the malaria control drive, we can anticipate a reduction in malaria burden that ensures that our children, pregnant women, indeed, all Nigerians are shielded from the disease.

    “We must work together to reduce the unnecessary deaths attributable to malaria and ultimately improve the well-being of citizens. I implore the Council to ensure best practices and innovative strategies in achieving its mandate,” the President said.

    Buhari used the occasion to thank the Chairman of the African Leaders Malaria Alliance (ALMA), President Uhuru Kenyatta of Kenya, the Executive Secretary of ALMA, RBM Partnership in Nigeria for their continuous support to the Federal Ministry of Health and the malaria programme, in particular.

    He also acknowledged the contributions of the Global Fund, the United States Agency for International Development, the President’s Malaria Initiative, Bill and Melinda Gates Foundation, WHO , UNICEF, UK Foreign and Commonwealth Development Office, other implementing partners, and the private sector.

    In separate remarks, the Minister of Health, Osagie Ehanire, and the Minister of State for Health, Joseph Ekumankama Nkama, said since 2010, Nigeria has been recording a continuous decline in malaria from 42 per cent in 2010, 27 per cent in 2015 to 23 per cent in 2018.

    Quoting figures from the 2010 Nigeria Malaria Indicator Survey and the 2018 Nigeria Demographic and Health Survey, they attributed the decline to the thorough implementation of the National Malaria Strategic Plan (NMSP).

    Both ministers, however, admitted that funding gap has impacted the implementation of the malaria programmes in Nigeria, adding that the country needs N1.89 trillion to reduce malaria prevalence and mortality by 2025.

    Ekumankama said: ‘‘The biggest challenge confronting us, which prevents the elimination of malaria, to ensure a malaria-free nation in the shortest possible time is inadequate finances to fund the NMSP.

    “We are currently implementing NMSP of 2021 to 2025, with the intent to achieve a parasitic prevalence of less than 10 per cent and reduce mortality attributable to malaria to less than 50 deaths per 1000 live births by the year 2025. It will take about N1.89 trillion to implement this plan.

    “However, in the first year of its implementation we had an estimated deficit of over N150 billion and in 2022, we already have a deficit of over N170 billion.”

    In his acceptance speech, Dangote thanked the President and all members of the Council for entrusting him with the enormous responsibility, pledging to work hard to achieve the mandate.

    “I must confess that this resonates with my current role as the Nigerian Ambassador for Malaria, my role on the Global End Malaria Council and with the work that my Foundation is doing to mobilise the private sector to support malaria control in Nigeria and Africa at large,’’ he said.

    The Council members are: Shehu Ibrahim, Permanent Secretary, Office of the Vice President on Political and Economic Affairs, Governor Kayode Fayemi of Ekiti State and Chairman of the Nigeria Governors’ Forum (NGF), Sen. Yahaya Oloriegbe, Chairman, Senate Committee on Health, Hon. Abubakar Dahiru, Chairman, House Committee on AIDS, TB and Malaria, Dr Ehanire, Hon. Ekumankama, Mahmuda Mamman, Permanent Secretary, Federal Minister of Health.

    Others include, Tony Elumelu, Chairman, Board of Directors, UBA, Folurunsho Alakija, CEO, Rose of Sharon Group, Herbert Wigwe, CEO, Access Bank, Femi Otedola, CEO Forte Oil, Hajiya Lami Lau, President, National Council of Women Societies, John Cardinal Onaiyekan, Emertius Archbishop of Abuja Catholic Archdiocese, Alhaja Rafiyat Sanni, National Amira, Federation of Muslim Women Nigeria (FOWAN) and Dr Perpetua Uhomoibhi, NEMC Secretariat/National Coordinator, National Malaria Elimination Programme (NMEP).

  • Reps set to probe World Bank’s $300m Malaria IMPACT Funds

    Reps set to probe World Bank’s $300m Malaria IMPACT Funds

     

     

    The House of Representatives has mandated its relevant committees to investigate the late/non-disbursement of the $300 million World Bank supported Immunisation Plus and Malaria Progress by Accelerating Coverage and Transforming Services Project (IMPACT) funds in Nigeria.

    The move was sequel to the adoption of a motion of public importance, on the urgent need to investigate Nigeria’s losses in fight against Malaria, promoted by Benjamin Kalu (APC Abia) and two others at plenary on Wednesday.

    The World Bank’s IMPACT fund is a project facility designed as a vehicle to fast-track government’s intervention in malaria to reduce under-five mortality in the Nigeria for 13 beneficiary states.

    The committees, including those on AIDS, Tuberculosis and Malaria Control; Health Services; and Health Institutions
    are to also conduct an investigation into the reported underperformance and down rating of the National Malaria Elimination Programme (NMEP) by the office of the Inspector General of the Global Fund and report back in six weeks.

    Debating the motion Kalu said Nigeria alone accounts for 27 percent of malaria cases and 31 percent of malaria deaths worldwide, with malaria killing no fewer than 200,000 Nigerians and afflicting 61 million others in 2021.

    The lawmaker observed that despite efforts to contain malaria, Nigeria loses over $1.1 billion (N645.7 billion) yearly to prevention and treatment of the disease as well as other costs.

    He said, “the House is aware that Nigeria made notable progress in the scaling up and impact of malaria interventions over the years. For instance, utilization of mosquito nets in children less than five years of age increased significantly, from 6% to 49% and parasite prevalence also came down from 42% in 2010 to 23% in 2018.

    “Concerned however, that the recent 2021 Malaria Indicator survey analysis shows that Nigeria is sliding back with a parasite prevalence of 32%.

    “Aware that National Malaria Elimination Programme (NMEP) is the body responsible for formulating and facilitating policy and guidelines, coordinating the activities of partners and stakeholders on malaria control activities, providing technical support to states malaria programs, LGAs and stakeholders; mobilizing resources, monitoring and evaluating progress and outcomes in malaria elimination efforts across the country.

    “Worried by a recent report from the Office of the Inspector General of the Global Fund dated March 24, 2022, indicating that NMEP has fallen from a B1 to B2 rating within 6 months, an unfortunate trend that undermines Nigeria’s shot at accessing future grants and partnerships in the fight to eliminate Malaria’.

    The lawmaker said Nigeria is presently one of the biggest beneficiaries of the Global Fund grant with the current grant 2021 to 2023 value of $ 412 million.

    He expressed concern that the global fund grant is under threat due to poor absorption, poor performance and lack of domestic resource mobilisation which will have a negative impact in the next grant allocation and other partnership opportunities.

    Further noted that: the effect of this poor performance by NMEP is already evident in the fact that the World Health Organization (WHO) has now neglected Nigeria in favour of Ghana, Kenya, and Malawi for the roll out of the RTS-S/AS01 malaria vaccine.

    He said, “the House is mindful that with the onset of the rainy season, Nigeria is in dire need of malaria interventions.

    “Recalls that on 2nd December 2020 the Federal Government inaugurated the National Steering Committee of World Bank Supported Immunization Plus and Malaria Progress by Accelerating Coverage and Transforming Services Project (IMPACT), a $300 million project facility designed as a vehicle to fast-track government’s intervention in malaria to reduce under-five mortality in the Nigeria for 13 beneficiary states.

    “Concerned that almost 2 years later, despite the preparedness of the World Bank and the Islamic Bank to disburse the funds, the IMPACT Project is yet to commence.

    “Further concerned that in the past year, non-WHO approved mosquito nets have been procured and distributed in Nigeria without any rejection of this product by the leadership of the National Malaria Programme.

    “Worried that more of these non-WHO approved mosquito nets are being imported into Nigeria despite a resolution by this House calling for the prioritization of local content in the procurement of Malaria commodities.

    “Concerned that if nothing is done to address the underperformance of NMEP and improve the quality of malaria interventions in Nigeria, our dear country will continue to lose over $1.1 billion (N645.7 billion) yearly in addition to hundreds of thousands of lives”.

    The house adopted the motion and invited the leadership of the National Malaria Programme to explain why defective mosquito nets are still being procured, imported and distributed in Nigeria against World Health Organization standards and local content directives from this House.

    It also urged the Federal Ministry of Health, the National Malaria Programme, and other relevant Ministries, Departments and Agencies to comply with the resolution to prioritise local content when procuring Malaria Commodities using funds from the IMPACT projects facility.

  • Spread of Monkeypox outbreak can be stopped with right strategies – WHO

    Spread of Monkeypox outbreak can be stopped with right strategies – WHO

    The World Health Organisation (WHO) on Tuesday said the rapid spread of the Monkeypox outbreak could be stopped with the right strategies in the right groups.

    WHO Technical Lead on Monkeypox, Dr Rosamund Lewis, said at a press briefing at the United Nations (UN) health agency’s headquarters in Geneva that countries should act fast to stop the spread of the virus.

    Lewis said, “time is going by and we all need to pull together to make that happen”.

    The UN correspondent of newsmen reports that WHO Director-General Tedros Ghebreyesus, on Saturday, declared the spread of the virus to be a Public Health Emergency of International Concern (PHEIC).

    PHEIC is WHO’s the highest level of alert.

    “Through this, we hope to enhance coordination, cooperation of countries and all stakeholders, as well as global solidarity,” Lewis said.

    WHO assessed the risk posed to public health by Monkeypox in the European region as high, but at the global level as moderate.

    With “other regions not at the moment as severely affected”, declaring a PHEIC was necessary “to ensure the outbreak was stopped as soon as possible”.

    In 2022, there have been more than 16,000 confirmed cases of monkeypox in more than 75 countries. Lewis said the real number was probably higher.

    Lewis pointed out that in the Democratic Republic of the Congo, several thousand cases were suspected, but testing facilities are limited.

    “The global dashboard did not include suspected cases,” she said.

    Some 81 children under the age of 17 were reported as having been infected globally, she added, with the majority of cases being among young men, with the median age being 37.

    First identified in monkeys, the virus is transmitted chiefly through close contact with an infected person.

    Until 2022, the virus which causes Monkeypox has rarely spread outside Africa where it is endemic. But reports of a handful of cases in Britain in early May signalled that the outbreak had moved into Europe.

    Lewis pointed out that stigma and discrimination must be avoided, as that would harm the response to the disease.

    “At the moment the outbreak is still concentrated in groups of men who have sex with men in some countries, but that is not the case everywhere.

    “It is really important to appreciate also that stigma and discrimination can be very damaging and as dangerous as any virus itself,” she said.

    Monkeypox could cause a range of signs and symptoms, including painful sores.  Some people developed serious symptoms that need care in a health facility.

    Those at higher risk for severe disease or complications include pregnant women, children, and immunocompromised persons.

    Lewis said WHO was working with the Member States and the European Union on releasing vaccines, and with partners to determine a global coordination mechanism.

    She emphasised that mass vaccination was not required, but the WHO had recommended post-exposure vaccination.

    Vaccine sharing should be done according to public health needs, country by country and location by location. Not all regions had the same epidemiology, she explained.

    Lewis stressed that countries with manufacturing capacity for smallpox and Monkeypox diagnostics, vaccines or therapeutics should increase production.

    Countries and manufacturers should work with WHO to ensure they are made available based on public health needs, solidarity and at a reasonable cost to countries where they were most needed.

    Lewis explained that some 16.4 million vaccines were currently available in bulk but needed to be finished. The countries currently producing vaccines are Denmark, Japan, and the United States.

    She reminded that the current recommendation for persons with Monkeypox was to isolate and not travel until they recovered; contact cases should be checking their temperature and monitoring possible other symptoms for the period of nine to 21 days.

    “When someone is vaccinated it takes several weeks for the immune response to be generated by the body,” she said.

    According to Lewis, the name “Monkeypox” is already present in the International Classification of Diseases, and a process had to be followed in order to potentially change its name.